Menu
Recruiting NCT03413982

Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers

— Observational Bladder Cancer

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Registry.
Who it may be relevant to
Registry conditions: Bladder Cancer. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

The purpose of this study is to create a registry, which is a "bank" of information about patients who have had similar medical conditions and treatments. The registry will be used by researchers to learn more about long term outcome of patients with bladder cancer, how bladder cancer tissues are related to tumor development, recurrence and survival.

Interventions

  • Other Registry
    Patient registry

Primary outcome measures

  • Blood, urine and tissue characteristics of bladder cancer patients [Time frame: 24 months]

Eligibility criteria

Inclusion criteria

  • Patients who present to clinic with presumed bladder cancer or have a diagnosis of bladder cancer are eligible to participate
  • Patients can participate in any additional research studies during the patients' participation within this protocol.

Exclusion criteria

  • Patients who do not have presumed bladder cancer will not be eligible

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

United States · 1 center
  • University of Kansas Medical Center — Kansas City

Identifiers

NCT: NCT03413982 · STUDY00141546

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗